Norwegian study reports HIV remission after stem cell transplant, offering rare insight into potential cure pathways for the ...
First successful allogeneic stem cell transplant using deceased donor in blood cancer clinical trial
For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University ...
Please provide your email address to receive an email when new articles are posted on . The addition of post-transplant cyclophosphamide to sirolimus and cyclosporine reduced chronic GVHD. Efforts are ...
A man in Norway has achieved long-term HIV remission after a stem cell transplant from his brother. Researchers say rare ...
As part of consolidation therapy, patients may receive allogenic hematopoietic stem cell transplantation (HCT). HCT involves the replacement of a patient's normal source of bone marrow cells by ...
Stem cell transplants remain essential for blood cancers, with expanded donor options including half-matched family members and umbilical cord blood. Cyclophosphamide has improved graft-versus-host ...
Interesting Engineering on MSN
First sibling stem cell transplant cures man with HIV after 20-year infection
A 63-year-old Norwegian man is the latest person to achieve long-term remission from HIV, ...
After receiving a stem cell transplant from his brother, a 63-year-old Norwegian man known as the "Oslo patient" has become ...
Outcomes of split-dose lymphocyte-adjusted rabbit ATG in allogeneic stem cell transplant recipients.
Outcomes of post-allogeneic hematopoietic stem cell transplant (HSCT) maintenance therapy in FLT3-mutated, IDH-mutated, or high relapse-risk myeloid malignancies: A single-center experience. Outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results